Literature DB >> 14759551

Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.

Lene Hansen1, Bolette Hartmann, Hitoshi Mineo, Jens J Holst.   

Abstract

Glucagon-like peptide-1 (GLP-1) is released from intestinal L-cells in response to ingestion of meals. The mechanisms regulating its secretion are not clear, but local somatostatin (SS) restrains GLP-1 secretion. We investigated feedback and substrate regulation of GLP-1 and SS secretion, using isolated perfused porcine ileum (n=17). Effluents were measured for GLP-1 and SS. Perfusion pressure and motility were recorded. Investigated parameters included spontaneous fluctuations, changes in perfusate glucose concentrations (3.5, 5, 11 mM) and addition of insulin (1 nM). We also investigated the effect of proglucagon products, glucagon (10 nM), GLP-1 and GLP-2 (0.1, 1, and 10 nM) on GLP-1 and SS secretion, as well as on glucagon-like peptide-2 (GLP-2), peptide YY (PYY) and GIP secretion, all possible product of L-cells or neighbour cells. Perfusate glucose concentration dose-dependently stimulated GLP-1 secretion (p=0.011). Insulin had no effect. Glucagon weakly stimulated GIP secretion. GLP-1 stimulated SS secretion and motor activity, but inhibited GLP-2, GIP and PYY secretion and perfusion pressure. GLP-2 weakly stimulated SS secretion. We conclude (a) that GLP-1 secretion is influenced by perfusate glucose concentration and (b) that L-cell secretion is feedback regulated by GLP-1 itself, probably via paracrine SS activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759551     DOI: 10.1016/j.regpep.2003.10.021

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  27 in total

Review 1.  Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Authors:  M A Nauck; I Vardarli; C F Deacon; J J Holst; J J Meier
Journal:  Diabetologia       Date:  2010-09-25       Impact factor: 10.122

2.  Contributions of fat and protein to the incretin effect of a mixed meal.

Authors:  Guillaume Carrel; Léonie Egli; Christel Tran; Philippe Schneiter; Vittorio Giusti; David D'Alessio; Luc Tappy
Journal:  Am J Clin Nutr       Date:  2011-08-17       Impact factor: 7.045

3.  Spatiotemporal Modeling of Triggering and Amplifying Pathways in GLP-1 Secreting Intestinal L Cells.

Authors:  Alessia Tagliavini; Morten Gram Pedersen
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

Review 4.  Physiology of incretins in health and disease.

Authors:  Carolyn F Deacon; Bo Ahrén
Journal:  Rev Diabet Stud       Date:  2011-11-10

5.  Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance.

Authors:  Kim A Sjøberg; Stephen Rattigan; Jacob F Jeppesen; Anne-Marie Lundsgaard; Jens J Holst; Bente Kiens
Journal:  J Physiol       Date:  2015-03-19       Impact factor: 5.182

6.  Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.

Authors:  Wendell J Lu; Qing Yang; Li Yang; Dana Lee; David D'Alessio; Patrick Tso
Journal:  Lipids       Date:  2012-06       Impact factor: 1.880

Review 7.  The effect of glucagon-like peptide 1 on cardiovascular risk.

Authors:  Jacob Sivertsen; Jaya Rosenmeier; Jens J Holst; Tina Vilsbøll
Journal:  Nat Rev Cardiol       Date:  2012-01-31       Impact factor: 32.419

8.  Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

Authors:  Gareth E Lim; Guan J Huang; Nina Flora; Derek LeRoith; Christopher J Rhodes; Patricia L Brubaker
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

9.  Glucose sensing in L cells: a primary cell study.

Authors:  Frank Reimann; Abdella M Habib; Gwen Tolhurst; Helen E Parker; Gareth J Rogers; Fiona M Gribble
Journal:  Cell Metab       Date:  2008-12       Impact factor: 27.287

10.  Pancreatojejunal leakage after pancreas head resection: anatomic and surgeon-related factors.

Authors:  O Kollmar; M R Moussavian; M Bolli; S Richter; M K Schilling
Journal:  J Gastrointest Surg       Date:  2007-09-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.